PURPOSE OF REVIEW: Helminthic parasites and many allergens trigger highly polarized Th2-type immune responses. In most helminth infections, the Th2 response often leads to parasite expulsion or sequestration. During murine Schistosoma mansoni infection, however, the parasites persist and the chronic Th2 response induces severe pathological changes in the gut and liver. Thus, the study of schistosome infections in mice has become a popular model to study the pathogenesis of Th2 cytokine-mediated disease. This review will discuss recent findings from the schistosomiasis model that may be relevant to the understanding of allergic inflammation, asthma and Th2 cytokine biology in general. RECENT FINDINGS: Evidence is accumulating that the Th2 pathway is not a 'default pathway' but one that is actively instructed by mechanisms that are only beginning to be understood. Other areas of intensive investigation include studies on alternatively activated macrophages, the role of dendritic cells in Th2 response development, the inhibitory function of IL-10, regulatory T-cells and decoy receptors on chronic Th2-mediated inflammation, and the role of chitinases in mediating Th2 disease. Finally, the development of novel eosinophil-deficient mice has also accelerated our understanding of the contribution of this important cell type to Th2 immunity. SUMMARY: Many findings from the schistosomiasis model have been subsequently demonstrated in models of allergic disease, illustrating the utility of this model to dissect basic mechanisms of Th2-mediated inflammation. Further study of helminth-induced Th2 responses may expedite the discovery of new therapeutics for a wide range of Th2-associated diseases.
PURPOSE OF REVIEW: Helminthic parasites and many allergens trigger highly polarized Th2-type immune responses. In most helminth infections, the Th2 response often leads to parasite expulsion or sequestration. During murineSchistosoma mansoni infection, however, the parasites persist and the chronic Th2 response induces severe pathological changes in the gut and liver. Thus, the study of schistosome infections in mice has become a popular model to study the pathogenesis of Th2 cytokine-mediated disease. This review will discuss recent findings from the schistosomiasis model that may be relevant to the understanding of allergic inflammation, asthma and Th2 cytokine biology in general. RECENT FINDINGS: Evidence is accumulating that the Th2 pathway is not a 'default pathway' but one that is actively instructed by mechanisms that are only beginning to be understood. Other areas of intensive investigation include studies on alternatively activated macrophages, the role of dendritic cells in Th2 response development, the inhibitory function of IL-10, regulatory T-cells and decoy receptors on chronic Th2-mediated inflammation, and the role of chitinases in mediating Th2 disease. Finally, the development of novel eosinophil-deficientmice has also accelerated our understanding of the contribution of this important cell type to Th2 immunity. SUMMARY: Many findings from the schistosomiasis model have been subsequently demonstrated in models of allergic disease, illustrating the utility of this model to dissect basic mechanisms of Th2-mediated inflammation. Further study of helminth-induced Th2 responses may expedite the discovery of new therapeutics for a wide range of Th2-associated diseases.
Authors: Makoto Ishii; Haitao Wen; Callie A S Corsa; Tianju Liu; Ana L Coelho; Ronald M Allen; William F Carson; Karen A Cavassani; Xiangzhi Li; Nicholas W Lukacs; Cory M Hogaboam; Yali Dou; Steven L Kunkel Journal: Blood Date: 2009-06-30 Impact factor: 22.113
Authors: Luke Barron; Amber M Smith; Karim C El Kasmi; Joseph E Qualls; Xiaozhu Huang; Allen Cheever; Lee A Borthwick; Mark S Wilson; Peter J Murray; Thomas A Wynn Journal: PLoS One Date: 2013-04-24 Impact factor: 3.240
Authors: Jonathan M Swartz; Kimberly D Dyer; Allen W Cheever; Thirumalai Ramalingam; Lesley Pesnicak; Joseph B Domachowske; James J Lee; Nancy A Lee; Paul S Foster; Thomas A Wynn; Helene F Rosenberg Journal: Blood Date: 2006-06-13 Impact factor: 22.113
Authors: Tiffany A Reese; Hong-Erh Liang; Andrew M Tager; Andrew D Luster; Nico Van Rooijen; David Voehringer; Richard M Locksley Journal: Nature Date: 2007-04-22 Impact factor: 49.962
Authors: Barbro N Melgert; Timothy B Oriss; Zengbiao Qi; Barbara Dixon-McCarthy; Marie Geerlings; Machteld N Hylkema; Anuradha Ray Journal: Am J Respir Cell Mol Biol Date: 2009-07-02 Impact factor: 6.914
Authors: Philip Bejon; Jedidah Mwacharo; Oscar Kai; Stephen Todryk; Sheila Keating; Brett Lowe; Trudie Lang; Tabitha W Mwangi; Sarah C Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill Journal: J Immunol Date: 2007-09-15 Impact factor: 5.422
Authors: Niyun Jin; Christina L Roark; Nobuaki Miyahara; Christian Taube; M Kemal Aydintug; J M Wands; Yafei Huang; Youn-Soo Hahn; Erwin W Gelfand; Rebecca L O'Brien; Willi K Born Journal: J Immunol Date: 2009-02-15 Impact factor: 5.422